Ivonne Regel

Ivonne Regel

Halle, NI, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort.

Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort.

Journal: European journal of internal medicine

Published: December 15, 2025

Dysregulated sphingolipid metabolismdrives pancreatic carcinogenesis through plasma membrane Kras enrichment.

Dysregulated sphingolipid metabolismdrives pancreatic carcinogenesis through plasma membrane Kras enrichment.

Journal: Gut

Published: October 23, 2025

Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review).

Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review).

Journal: International journal of oncology

Published: October 08, 2025

International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEG.

International Multidisciplinary Consensus Report on Definitions, Diagnostic Criteria, and Management of Fatty Pancreas: A Joint Statement Endorsed by EPC, APA, EASD, EASL, ESGAR, ESGE, ESP, ESPCG, ESPEN, ESPGHAN, IAP, JPS, KPBA, LAPSG, and UEG.

Journal: United European gastroenterology journal

Published: September 01, 2025

Addressing Pancreatic Exocrine Insufficiency and the Impact of Pancreatic Enzyme Replacement Therapy Shortages in Europe.

Addressing Pancreatic Exocrine Insufficiency and the Impact of Pancreatic Enzyme Replacement Therapy Shortages in Europe.

Journal: United European gastroenterology journal

Published: July 12, 2025

Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study.

Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study.

Journal: European journal of internal medicine

Published: July 03, 2025

Hereditary chronic pancreatitis induced plasticity cooperates with mutant Kras in early pancreatic carcinogenesis.

Hereditary chronic pancreatitis induced plasticity cooperates with mutant Kras in early pancreatic carcinogenesis.

Journal: Gut

Published: May 23, 2025

NLRP3 Inflammasome Activation-Induced Acute Papillitis as a Trigger of Acute Pancreatitis - A Novel Mechanism of Microlithiasis-Induced Acute Pancreatitis.

NLRP3 Inflammasome Activation-Induced Acute Papillitis as a Trigger of Acute Pancreatitis - A Novel Mechanism of Microlithiasis-Induced Acute Pancreatitis.

Journal: United European gastroenterology journal

Published: May 06, 2025

STING Ablation in T Cells Is Required for the Efficacy of STING Agonists in CAR-T Cell Immunotherapy of Pancreatic Cancer.

STING Ablation in T Cells Is Required for the Efficacy of STING Agonists in CAR-T Cell Immunotherapy of Pancreatic Cancer.

Journal: Gastroenterology

Published: March 01, 2025

Autoimmune pancreatitis, pancreatic and extrapancreatic cancer (AIPPEAR): a multicentre, retrospective study protocol.

Autoimmune pancreatitis, pancreatic and extrapancreatic cancer (AIPPEAR): a multicentre, retrospective study protocol.

Journal: BMJ open

Published: February 16, 2025

Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study.

Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study.

Journal: The lancet. Gastroenterology & hepatology

Published: November 22, 2024

Gram-negative bacteria-driven increase of cytosolic phospholipase A2 leads to activation of Kupffer cells.

Gram-negative bacteria-driven increase of cytosolic phospholipase A2 leads to activation of Kupffer cells.

Journal: Cellular and molecular life sciences : CMLS

Published: February 15, 2024

Showing 1-12 of 52

Last Updated: 09/26/2026